Logotipo del repositorio
Comunidades y Colecciones
Estadísticas
¿Nuevo Usuario? Pulse aquí para registrarse¿Has olvidado tu contraseña?
  1. Inicio
  2. Producción Científica UPeU
  3. Publicaciones
  4. The Efficacy of a Trivalent Inactivated Salmonella Vaccine Combined with the Live S. Gallinarum 9R Vaccine in Young Layers after Experimental Infections with S. Enteritidis, S. Typhimurium, and S. Infantis

The Efficacy of a Trivalent Inactivated Salmonella Vaccine Combined with the Live S. Gallinarum 9R Vaccine in Young Layers after Experimental Infections with S. Enteritidis, S. Typhimurium, and S. Infantis

Author(s)
Melanie Caballero-García
Rober Rojas
Silvia Ascanio
Leandro Hipólito Olmos
Rosana Malena
Jorgelina Lomónaco
Paula Nievas
Paula Chero
Julio Lévano-Gracía
Alfredo Mendoza-Espinoza
Date Issued
12 de julio de 2022
Type
Article
Volume
10
Issue
7
Start Page
1113
End Page
1113
DOI
10.3390/vaccines10071113
Abstract
Worldwide, poultry infections by Salmonella are the cause of significant economic losses, not only due to reduced production (due to fowl typhoid disease), but also considering the efforts and control measures that must be constantly applied, especially due to zoonotic serovars. Poultry is a common reservoir of Salmonella and its transmission into the food chain is a risk for humans. The vaccination of layers plays an important role in the overall efforts to prevent Salmonella infections. An inactivated trivalent vaccine was prepared with S. Enteritidis, S. Typhimurium, and S. Infantis strains. Infection trials were performed to evaluate the efficacy of three vaccination schedules using inactivated and live S. Gallinarum 9R vaccines. For this purpose, at week 5 of life, one subcutaneous dose of live S. Gallinarum 9R vaccine (1–5 × 107 CFU) was given to Groups 1 and 2. At weeks 8 and 11 of life, chickens were also vaccinated with one (Group 1) or two (Groups 2 and 3) intramuscular doses of the inactivated oil-adjuvant trivalent vaccine (1 × 108 CFU/dose of each antigen). Group 4 consisted of chickens that remained unvaccinated (control). At week 14 of life, the efficacy of the vaccination plans was evaluated in three separate inoculation trials with S. Enteritidis, S. Typhimurium, or S. Infantis. After vaccination with the inactivated vaccine, homologous antibody production was observed, and after challenge, a significant reduction in the faecal shedding, invasion, and colonization of S. Typhimurium and S. Infantis was achieved by all vaccination schedules, while the vaccination with at least one dose of the live S. Gallinarum 9R vaccine was necessary to obtain such a significant protection against S. Enteritidis infection.
Subjects

Salmonella enteritidi...

Microbiology

Virology

Salmonella

Biology

Bacteria

Genetics

Salmonella enteritidi...

Microbiology

Virology

Salmonella

Biology

Bacteria

Life Sciences Agricul...

Health Sciences Medic...

Health Sciences Medic...

Metrics
Get Involved!
  • Source Code
  • Documentation
  • Slack Channel
Make it your own

DSpace-CRIS can be extensively configured to meet your needs. Decide which information need to be collected and available with fine-grained security. Start updating the theme to match your Institution's web identity.

Need professional help?

The original creators of DSpace-CRIS at 4Science can take your project to the next level, get in touch!

Desarrollado con Software DSpace-CRIS - Extensión mantenida y optimizada por 4Science

  • Accessibility settings
  • Política de privacidad
  • Acuerdo de usuario final
  • Enviar Sugerencias